• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 23, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Study: Keloids linked to early onset and late stage breast cancer

Bioengineer by Bioengineer
January 24, 2019
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

DETROIT – Findings from a new study conducted by researchers at Henry Ford Health System suggest a link between keloids and increased risk of being diagnosed with breast cancer, particularly among African Americans. Keloids are benign fibroproliferative tumors, which can result in excessive growths of scar-like tissue on the skin. Keloids have been reported to affect some 11 million people worldwide. Despite this prevalence, the exact cause of keloid formation is unknown.

The multi-disciplinary research team hypothesized African American women with a history of keloids would reflect a population of breast cancer patients with aggressive tumors and poor outcomes. Medical record review of 13,033 patients with scar codes in the Henry Ford Health System electronic health record, between 2005-2015 was conducted.

Of these patients, 255 also had a concurrent breast cancer diagnosis. Of this group of 255 patients with a breast cancer diagnosis, 102 had a confirmed history of keloids and 152 did not have keloids. Using this patient cohort, the researchers conducted multivariate analysis to identify associations between breast cancer related clinical factors, and keloid status.

The researchers found a race-specific age association, with African American patients displaying significantly younger ages at breast cancer diagnosis in keloid-positive patients, average age 52-years-old, versus keloid-negative patients, average age 58-years-old. In addition, keloid patients had a larger percentage of late stage breast cancers (11.7% versus 4.8%). The group hypothesizes that ethnic variations in tumor immune response may underlie their unique cancer risk.

“It is well-documented that keloids and certain aggressive breast cancer such as triple negative and inflammatory types disproportionately affect African American Women,” said Lamont R Jones, M.D., MBA, vice chair for the Department of Otolaryngology – Head and Neck Surgery at Henry Ford Health System, and principal investigator of this study. “We need to better understand how immune-related differences, specific to African Americans, result in more aggressive types of cancer. While the results of this study are preliminary, we believe further investigating a possible link between breast cancer and keloids may provide more insight.”

###

The study is being presented at the Triological Society’s Combined Section Meeting Jan. 24-26 in Coronado, California.

The research team consisted of Lamont R. Jones M.D., MBA, Edward M. Walton BS, Brittany D Jenkins Ph.D., Vanessa P. Chu, Haythem Y. Ali, M.D., Christine M Nesland-Dudas Ph.D., Eleanor M Walker Ph.D. and Melissa B. Davis, Ph.D.

Media Contact
Jeff Adkins
[email protected]
586-307-2027
https://www.henryford.com/news/2019/01/keloids-linked-to-early-onset-and-late-stage-breast-cancer

Tags: Breast CancercancerDermatologyMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Omega-3 Boosts Immunity in Gastric Cancer Surgery

Omega-3 Boosts Immunity in Gastric Cancer Surgery

August 23, 2025
DWI-Guided vs. MRI-Based IMRT in Head & Neck

DWI-Guided vs. MRI-Based IMRT in Head & Neck

August 23, 2025

Uncovering Cutaneous SCC Genomic Diversity via Single-Cell DNA

August 23, 2025

Moffitt Study Reveals Lymphoma Speeds Up Aging in Immune Cells and Tissues

August 23, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Exploring Bacterial Community Layers in Bohai Sea Sediments

Enhanced Hydrogen Peroxide Sensing with CuO/TiO2 Electrodes

Omega-3 Boosts Immunity in Gastric Cancer Surgery

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.